What does VERIMED MEDICAL SUPPLY do?

VERIMED MEDICAL SUPPLY is a wholesaler in Wetteren. Private Limited, started on 6 June 1996, 1 establishment.

What is the address of VERIMED MEDICAL SUPPLY?

The registered office of VERIMED MEDICAL SUPPLY is located at Serskampsteenweg 238, 9230 Wetteren.

Is VERIMED MEDICAL SUPPLY still active?

Yes. According to the CBE (31 October 2026) VERIMED MEDICAL SUPPLY is active, legal situation “Normale toestand”, started on 6 June 1996.

Is VERIMED MEDICAL SUPPLY registered on Peppol?

Yes, VERIMED MEDICAL SUPPLY is registered on the Peppol network with ID 0208:0458133869.

What is the enterprise number of VERIMED MEDICAL SUPPLY?

The enterprise number of VERIMED MEDICAL SUPPLY is BE0458133869.

When was VERIMED MEDICAL SUPPLY founded?

VERIMED MEDICAL SUPPLY was founded on 6 June 1996.

Who are the directors of VERIMED MEDICAL SUPPLY?

According to the 2025 annual accounts, the directors of VERIMED MEDICAL SUPPLY are: Leo VERBRUGGHE.

Is VERIMED MEDICAL SUPPLY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 June 1996; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did VERIMED MEDICAL SUPPLY make in 2025?

VERIMED MEDICAL SUPPLY recorded a loss after taxes of € 6,515 in financial year 2025.

What is the revenue of VERIMED MEDICAL SUPPLY?

As a small company, VERIMED MEDICAL SUPPLY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 28,238.

VERIMED MEDICAL SUPPLY (Private Limited) - Wetteren

Dossier VERIMED MEDICAL SUPPLY, printed on 1 November 2026 from databakkes.be/en/0458133869/verimed-medical-supply. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

VERIMED MEDICAL SUPPLY from Wetteren, company number BE0458133869, closed financial year 2025 with a result of € -6,515 after tax. For that financial year VERIMED MEDICAL SUPPLY recorded a gross margin of € 28,238 and equity of € 61,262. Compared with financial year 2024, the result moved from € 8,390 to € -6,515. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 8, 2026.

What it is worth Healthy

€ 61,262

▼ 10% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -6,515

▼ still € 8,390 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 33,220

▲ 38% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 23,262.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 31,363

▲ 7% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

€ 1,691

▼ 1% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 17,278

▼ 51% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 9,483

▼ 2% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 55,952 Gross margin 2022: € 55,952 First fiscal year in the series	€ 14,741 Gross margin 2023: € 14,741 ▼ 74% vs 2022 (€ 55,952) Unfavourable step	€ 46,036 Gross margin 2024: € 46,036 ▲ 212% vs 2023 (€ 14,741) Favourable step	€ 28,238 Gross margin 2025: € 28,238 ▼ 39% vs 2024 (€ 46,036) Unfavourable step	▼ 39%
Profit after taxes	€ 15,350 Profit after taxes 2022: € 15,350 First fiscal year in the series	€ -17,245 Profit after taxes 2023: € -17,245 ▼ € 32,596 vs 2022 (€ 15,350) Unfavourable step	€ 8,390 Profit after taxes 2024: € 8,390 ▲ € 25,635 vs 2023 (€ -17,245) Favourable step	€ -6,515 Profit after taxes 2025: € -6,515 ▼ € 14,905 vs 2024 (€ 8,390) Unfavourable step	▼ € 14,905
Equity	€ 107,225 Equity 2022: € 107,225 First fiscal year in the series	€ 89,979 Equity 2023: € 89,979 ▼ 16% vs 2022 (€ 107,225) Unfavourable step	€ 67,777 Equity 2024: € 67,777 ▼ 25% vs 2023 (€ 89,979) Unfavourable step	€ 61,262 Equity 2025: € 61,262 ▼ 10% vs 2024 (€ 67,777) Unfavourable step	▼ 10%
Total debts	€ 54,359 Total debts 2022: € 54,359 First fiscal year in the series	€ 46,524 Total debts 2023: € 46,524 ▼ 14% vs 2022 (€ 54,359) Favourable step	€ 49,824 Total debts 2024: € 49,824 ▲ 7% vs 2023 (€ 46,524) Unfavourable step	€ 29,040 Total debts 2025: € 29,040 ▼ 42% vs 2024 (€ 49,824) Favourable step	▼ 42%
Cash	€ 31,294 Cash 2022: € 31,294 First fiscal year in the series	€ 22,965 Cash 2023: € 22,965 ▼ 27% vs 2022 (€ 31,294) Unfavourable step	€ 24,141 Cash 2024: € 24,141 ▲ 5% vs 2023 (€ 22,965) Favourable step	€ 33,220 Cash 2025: € 33,220 ▲ 38% vs 2024 (€ 24,141) Favourable step	▲ 38%
Retained profit	€ 38,633 Retained profit 2022: € 38,633 First fiscal year in the series	€ 21,387 Retained profit 2023: € 21,387 ▼ 45% vs 2022 (€ 38,633) Unfavourable step	€ 29,777 Retained profit 2024: € 29,777 ▲ 39% vs 2023 (€ 21,387) Favourable step	€ 23,262 Retained profit 2025: € 23,262 ▼ 22% vs 2024 (€ 29,777) Unfavourable step	▼ 22%
Bank debt	€ 1,676 Bank debt 2022: € 1,676 First fiscal year in the series	€ 1,703 Bank debt 2023: € 1,703 ▲ 2% vs 2022 (€ 1,676) Unfavourable step	€ 1,705 Bank debt 2024: € 1,705 Unchanged (€ 1,703) Unfavourable step	€ 1,691 Bank debt 2025: € 1,691 ▼ 1% vs 2024 (€ 1,705) Favourable step	▼ 1%
Balance sheet total	€ 161,584 Balance sheet total 2022: € 161,584 First fiscal year in the series	€ 136,504 Balance sheet total 2023: € 136,504 ▼ 16% vs 2022 (€ 161,584) Unchanged	€ 117,601 Balance sheet total 2024: € 117,601 ▼ 14% vs 2023 (€ 136,504) Unchanged	€ 90,302 Balance sheet total 2025: € 90,302 ▼ 23% vs 2024 (€ 117,601) Unchanged	▼ 23%

Key figures of VERIMED MEDICAL SUPPLY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to VERIMED MEDICAL SUPPLY?

What happened at VERIMED MEDICAL SUPPLY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 8, 2026 New annual accounts for financial year 2025: loss of € 6,515 (▼ € 14,905 vs 2024). Source: NBB ↗
Jun 17, 1996 New establishment in Wetteren. KBO
1996 Leo VERBRUGGHE became a director. NBB
Jun 6, 1996 Start of the company according to the CBE. KBO

In short

From € 15,350 profit in 2022 to € 6,515 loss in 2025.

Paid € 18,894 in corporate taxes since 2022.

Best year ever: 2022, with € 15,350 profit.

Original PDFs at the National Bank ↗

Management

Leo VERBRUGGHE

VERIMED MEDICAL SUPPLY

Behind VERIMED MEDICAL SUPPLY is Leo VERBRUGGHE.

Directors

According to the 2025 annual accounts

Leo VERBRUGGHE

Director

since 1996

Establishments

Establishment units

Physical locations of this company

Registered office

Serskampsteenweg 238

9230 Wetteren

2.076.922.923

Scheldestraat 18 box 12

9230 Wetteren

Active since 17 June 1996

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Weymeersch Boomkwekerij

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0458.133.869

VAT number

BE 0458.133.869

Registered office

Serskampsteenweg 238, 9230 Wetteren

Names & denominations

VERIMED MEDICAL SUPPLY

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

6 June 1996

Peppol

Active · Active since 17 Nov 2025

Contact

[email protected]

Activities · NACE

Groothandel in farmaceutische en medische artikelen

Groothandel in farmaceutische producten

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

VERIMED MEDICAL SUPPLY

Financials

What happened to VERIMED MEDICAL SUPPLY?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions